Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration

In patients with the frontal variant of frontotemporal lobar degeneration (fv‐FTLD), behavioral abnormalities may vary from apathy with motor slowness (apathetic form) to disinhibition with agitation (disinhibited form). These clinical presentations may be related to specific regional cerebral dysfunction and to deficit in the serotoninergic system. We studied cerebral glucose uptake using 18F‐fluorodeoxyglucose and positron emission tomography in 18 patients fulfilling clinical criteria for fv‐FTLD and showing, respectively, an apathetic or disinhibited behavioral syndrome. In eight of these patients, we also evaluated the 5‐hydroxytryptamine‐2A receptor cerebral receptor distribution with [11C]MDL and positron emission tomography. We found a reduction of frontal glucose metabolism in the whole group of fv‐FTLD patients. Apathetic syndrome was associated with a prevalent dorsolateral and frontal medial hypometabolism, whereas the disinhibited syndrome demonstrated a selective hypometabolism in interconnected limbic structures (the cingulate cortex, hippocampus/amygdala, and accumbens nucleus). The in vivo measurements of [11C]MDL indicated a significant reduction of 5‐hydroxytryptamine‐2A receptors in orbitofrontal, frontal medial, and cingulate cortices. These 18F‐fluorodeoxyglucose positron emission tomography changes can be considered as specific functional markers of the different behavioral presentations in fv‐FTLD. The serotoninergic system dysfunction provides a rationale for therapeutic trials with selective serotonin reuptake inhibitors. Ann Neurol 2005;57:216–225

[1]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[2]  Karl J. Friston,et al.  Rapid Assessment of Regional Cerebral Metabolic Abnormalities in Single Subjects with Quantitative and Nonquantitative [18F]FDG PET: A Clinical Validation of Statistical Parametric Mapping , 1999, NeuroImage.

[3]  Karl Herholz,et al.  Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia , 2003, NeuroImage.

[4]  J R Hodges,et al.  The prevalence of frontotemporal dementia , 2002, Neurology.

[5]  J. Hodges,et al.  PROGRESSIVE FLUENT APHASIA WITH TEMPORAL LOBE A TROPHY , 1992 .

[6]  E. Lauterbach The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction , 1993 .

[7]  C Crouzel,et al.  Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone. , 1993, Brain : a journal of neurology.

[8]  S. Cappa,et al.  EFFECT OF AGE AND EDUCATION ON PERFORMANCE ON THE MINI‐MENTAL STATE EXAMINATION IN A HEALTHY OLDER POPULATION AND DURING THE COURSE OF ALZHEIMER'S DISEASE , 1995, Journal of the American Geriatrics Society.

[9]  Yan Yang Schmitt Frontotemporal dementia : evidence for impairment of ascending serotoninergic but not noradrenergic innervation Immunocytochemical and quantitative study using a graph method , 2022 .

[10]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[11]  et al.,et al.  Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET , 2002, NeuroImage.

[12]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[13]  B L Miller,et al.  Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD , 2002, Neurology.

[14]  Bruce L. Miller,et al.  Frontal lobe degeneration: clinical, neuropsychological and SPECT characteristics , 1998 .

[15]  B L Miller,et al.  Patterns of brain atrophy in frontotemporal dementia and semantic dementia , 2002, Neurology.

[16]  Gerald L. Russell,et al.  The temporal variant of frontotemporal dementia. , 1997, Brain : a journal of neurology.

[17]  C. Halldin,et al.  PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  S. Laureys,et al.  Comparison of Impaired Subcortico-Frontal Metabolic Networks in Normal Aging, Subcortico-Frontal Dementia, and Cortical Frontal Dementia , 1999, NeuroImage.

[19]  E. Capitani,et al.  Trail making test: normative values from 287 normal adult controls , 1996, The Italian Journal of Neurological Sciences.

[20]  A. Damasio,et al.  Severe disturbance of higher cognition after bilateral frontal lobe ablation , 1985, Neurology.

[21]  J. Hodges,et al.  Staging disease severity in pathologically confirmed cases of frontotemporal dementia , 2003, Neurology.

[22]  J. Hodges,et al.  Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment , 2003, Annals of neurology.

[23]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .

[24]  A. Kurz,et al.  Frontotemporal dementia: patient characteristics, cognition, and behaviour , 2002, International Journal of Geriatric Psychiatry.

[25]  Marcella Laiacona,et al.  Tre test clinici di memoria verbale a lungo termine: Taratura su soggetti normali. , 1986 .

[26]  Charles F. Reynolds,et al.  Reduced binding of [ 18 F ]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction , 1998, Brain Research.

[27]  D. Neary,et al.  Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and frontotemporal dementia , 1999, Journal of neurology, neurosurgery, and psychiatry.

[28]  Giovanna Rizzo,et al.  5-HT2A receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study , 2003, Psychopharmacology.

[29]  J. Hodges,et al.  Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer’s disease , 2000, Neurology.

[30]  B. Dubois,et al.  Clinicometabolic dissociation of cognitive functions and social behavior in frontal lobe lesions , 1998, Neurology.

[31]  Richard S. J. Frackowiak,et al.  A voxel‐based morphometry study of semantic dementia: Relationship between temporal lobe atrophy and semantic memory , 2000, Annals of neurology.

[32]  Marina Boccardi,et al.  The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia , 2003, Neurobiology of Aging.

[33]  G. Frisoni,et al.  Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease , 1999, Neurology.

[34]  P. Francis,et al.  Neurochemical Features of Frontotemporal Dementia , 1999, Dementia and Geriatric Cognitive Disorders.

[35]  B. Miller,et al.  Aggressive, socially disruptive and antisocial behaviour associated with fronto-temporal dementia , 1997, British Journal of Psychiatry.

[36]  P. Liddle,et al.  Brain serotonin2 receptors in major depression: a positron emission tomography study. , 2000, Archives of general psychiatry.

[37]  M. Lawton,et al.  Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living , 1969 .

[38]  J. Fuster Frontal Lobe and the Cognitive Foundation of Behavioral Action , 1996 .

[39]  D. Neary,et al.  The clinical pathological correlates of lobar atrophy. , 1993, Dementia.

[40]  J. Fuster Frontal lobes , 1993, Current Opinion in Neurobiology.

[41]  E Capitani,et al.  Raven's coloured progressive matrices: normative values on 305 adult normal controls. , 1987, Functional neurology.

[42]  F. Fazio,et al.  Effects of Fluvoxamine Treatment on the in Vivo Binding of [F-18]FESP in Drug Naive Depressed Patients: A Pet Study , 2000, NeuroImage.

[43]  C. Papagno,et al.  Verbal and spatial immediate memory span: Normative data from 1355 adults and 1112 children , 1987, The Italian Journal of Neurological Sciences.

[44]  A. Bava,et al.  Frontotemporal Dementia: Paroxetine as a Possible Treatment of Behavior Symptoms , 2002, European Neurology.

[45]  J. Hodges,et al.  Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. , 1992, Brain : a journal of neurology.

[46]  A. Cross Serotonin in Alzheimer‐type Dementia and Other Dementing Illnesses , 1990, Annals of the New York Academy of Sciences.

[47]  A. Nordberg,et al.  Neuroreceptor changes in Alzheimer disease. , 1992, Cerebrovascular and brain metabolism reviews.

[48]  B. Everitt,et al.  Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex , 2002, Neuroscience & Biobehavioral Reviews.

[49]  B Miller,et al.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.

[50]  Nick C Fox,et al.  Rates of global and regional cerebral atrophy in AD and frontotemporal dementia , 2001, Neurology.